Solid Biosciences Inc
SLDB
Get informed when a big investor buys or sells
+ FollowMarket Cap$961.85M
Close$
$0.44
95.7% downside
Current Fair Value
95.7% downsideOvervalued by 95.7% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $961.85 Million |
|---|---|
| Enterprise Value | $822.61 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-1.99 |
| Beta | 2.42 |
| Outstanding Shares | 143,688,701 |
Return
| Return on Equity | -55.36% |
|---|---|
| Return on Assets | -49.24% |
| Return on Invested Capital | -53.46% |
Valuation & Multiples
| P/E Ratio | -5.12 |
|---|---|
| PEG | -13.18 |
| Price to Sales | - |
| Price to Book Ratio | 5.14 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -3.93 |
| Enterprise Value to Net Income | -4 |
| Total Debt to Enterprise | 0.02 |
| Debt to Equity | 0.05 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 17, 2026
EPS Estimate
$-0.42
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationNext Earnings Call
Expected Date
November 2, 2026
EPS Estimate
$-0.37
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.0790▼ 39.42% |
|---|---|
| Total Calls | 168,300▼ 44.10% |
| Total Puts | 13,300▼ 90.67% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 104.55%▲ 13.75% |
|---|---|
| Total Invested | $1.15B▲ 59.95% |
| Investors Holding | 162▲ 13.00% |
ESG Score
No data